Gabriella Rákóczi

Gabriella Rákóczi

Auto-generated profile, based on publicly available information

Gabriella Rákóczi

Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
GRGabriella Rákóczi
Gabriella Rákóczi
JNJudit Nagy
Judit Nagy
SJShaghayegh Jozaee
Shaghayegh Jozaee
SJShirin Jozaee
Shirin Jozaee
BSBoglárka Lilla Szentes
Boglárka Lilla Szentes
ESEmese Sipter
Emese Sipter
Background: Prediabetes often remains undiagnosed until it progresses to type 2 diabetes mellitus (T2DM), particularly among individuals with obesity or a family history of diabetes. Conventional tests, including fasting plasma glucose, hemoglobin A1c, and the oral glucose tolerance test, provide only static snapshots of glycemia and may fail to capture variability and postprandial excursions. Continuous glucose monitoring (CGM) offers dynamic insight into glucose regulation and may complement traditional diagnostic tools. Methods: This systematic review and meta-analysis evaluated differences in CGM-derived metrics between individuals with prediabetes and those with normoglycemia. PubMed, EMBASE, and CENTRAL were searched from inception to September 3, 2025 (PROSPERO: CRD42024608658). The primary outcome was the mean amplitude of glycemic excursions (MAGE); secondary outcomes included time above range, 24-hour mean glucose, coefficient of variation, and time in range. Sixteen studies met the inclusion criteria, and ten were included in the quantitative synthesis ( n = 1657). Results: Prediabetes was consistently associated with higher CGM values compared with normoglycemia: MAGE (mean difference [MD] = 9.41 mg/dL, 95% confidence interval [CI]: 4.31, 15.31), TAR% (MD = 5.68%, 95% CI: 1.04, 10.32), and 24-hour mean glucose (MD = 7.91 mg/dL, CI: 6.27, 9.55). Conclusions: These results provide the first quantitative evidence that CGM can discriminate between prediabetes and normoglycemia, supporting its potential as a complementary tool for refined metabolic risk assessment. Further prospective studies are needed to determine its predictive value for progression to T2DM.

25 June 2026 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
GRGabriella Rákóczi
Gabriella Rákóczi
DCDávid Csányi
Dávid Csányi
RMRoland Molontay
Roland Molontay
Gergely AgócsGergely Agócs
Gergely Agócs
BSBoglárka Lilla Szentes
Boglárka Lilla Szentes
ESEmese Sipter
Emese Sipter

6 July 2026 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
GRGabriella Rákóczi
Gabriella Rákóczi
PHPéter Hegyi
Péter Hegyi
ESEmese Sipter
Emese Sipter